Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Overview

About this study

This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer and their families.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria - Patient:

  • Diagnosed with advanced NSCLC being treated with non-curative intent, and informed of advanced disease within the prior 8-12 weeks.
  • Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 3 (symptomatic and in bed >50% of the day).
  • The ability to read and respond to questions in English or Spanish.
  • Lives in a state where their institutions’ PC clinicians are licensed to practice.
  • Receiving primary cancer care at one of the participating sites.
  • Age > 18 years.

Inclusion Criteria - Caregiver:

  • Relative or friend who is identified by the patient participant and lives with the patient or has contact with them at least twice per week.
  • The ability to read and respond to questions in English or Spanish.
  • Age ≥ or 18 years.

Exclusion Criteria - Patient:

  • Already receiving PC or hospice services.
  • Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation.

Exclusion Criteria - Caregiver:

  • Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Konstantinos Leventakos, M.D., Ph.D.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions